Skip to content

Kintsugi

Enterprise Grade

Kintsugi develops voice biomarker infrastructure that analyzes short clips of free-form speech to detect signals consistent with depression and anxiety, aimed at helping risk-bearing health systems close mental healthcare gaps.

90

Overview

Kintsugi develops voice biomarker infrastructure that analyzes short clips of free-form speech to detect signals consistent with depression and anxiety. The company targets risk-bearing health systems, payers, and capitated provider organizations that want to identify at-risk members earlier and close gaps in mental healthcare access.

What Kintsugi Does

Kintsugi's core technology processes brief, unstructured speech samples to predict the presence of signals consistent with current depressive episodes. The company positions this as a way to help health plans and providers screen members at scale without relying solely on traditional questionnaires. The Kintsugi Voice (KV) API is designed for integration with just a few lines of code, allowing care organizations to embed voice-based screening into existing workflows.

Built for Risk-Bearing Health Systems

Kintsugi works with top payers and capitated health plans to identify at-risk members early, reduce costs, and improve outcomes. The product page is explicitly intended for professionals affiliated with health organizations and providers or payers investigating or currently using Kintsugi. This focus on risk-bearing entities reflects the company's mission to scale access to mental healthcare for all.

Clinical Evidence and Recognition

Kintsugi's peer-reviewed study on Voice AI was published in the Annals of Family Medicine, providing external validation of its approach. The company was also named to Forbes 50 AI, a recognition that may matter to health system decision-makers evaluating vendors. These milestones suggest Kintsugi has moved beyond early-stage development, though the underlying device remains investigational.

Implementation and Support

Kintsugi states that its product team works directly with clients to set teams up for success, including an implementation plan. The API-first design means integration can be lightweight, but the company still offers hands-on support for health organizations that need help deploying voice biomarker screening across member populations.

Important Limitations

Kintsugi is an investigational device not yet cleared by the FDA for any particular use. The company explicitly states that Kintsugi is not a substitute for a clinician diagnosis and should not be used to make medical decisions outside of clinician supervision. Any organization considering Kintsugi should treat it as a screening aid rather than a diagnostic tool, and should plan for clinician oversight in any care pathway that uses its output.

Where Kintsugi Fits

For payers and capitated health plans, Kintsugi offers a way to surface members who might otherwise go unnoticed until a crisis. By analyzing free-form speech, the system may reduce the burden on patients and providers compared to longer assessments. The company's mission—ensuring everyone who needs mental healthcare has access to the right care at the right time—frames the technology as a tool for population health rather than a standalone clinical solution.

Core features

  • Analyzes short clips of free-form speech to predict signals consistent with current depressive episodes
  • Kintsugi Voice (KV) API can be integrated with just a few lines of code
  • Works with top payers and capitated health plans to identify at-risk members early
  • Product team provides direct implementation support and planning
  • Peer-reviewed study on Voice AI published in the Annals of Family Medicine
  • Named to Forbes 50 AI
  • Investigational device not yet cleared by FDA for any particular use

Use cases

  1. 1Health plans and payers screening members for depression and anxiety at scale
  2. 2Capitated provider organizations identifying at-risk patients early to reduce costs and improve outcomes
  3. 3Clinicians using voice-based screening as a supplement to standard assessments
  4. 4Developers embedding the Kintsugi Voice API into existing care workflows

Strengths and things to check

Strengths

  • Uses short, free-form speech clips, which may reduce patient burden compared to lengthy questionnaires
  • API integration requires only a few lines of code
  • Backed by a peer-reviewed study in the Annals of Family Medicine
  • Designed specifically for risk-bearing health systems and payers

Things to check

  • Kintsugi is an investigational device and has not been cleared by the FDA for any particular use
  • It is not a substitute for a clinician diagnosis and should not be used to make medical decisions outside of clinician supervision
  • The product page is intended for professionals affiliated with health organizations, not direct-to-consumer use

Pricing

Subscription pricing is not listed.

Basic information

Added
Oct 10, 2026
Platforms
Web
Chinese & English
Not marked
API
Marked as supported
Self-hosting
Not marked
Best for
Kintsugi is built for health plans, payers, capitated provider organizations, and clinicians who want to identify at-risk members earlier and scale mental health screening.
Information updated
Oct 14, 2026
Website status
Checking
Corrections · Privacy · Data requests?
Contact us

Features, pricing and availability may change. Always verify details on the official website. Maintained by steven · Last updated Oct 14, 2026 →

Related tools

All categories

Nabla

Enterprise Grade

Nabla is a clinical AI layer that captures patient-clinician conversations and generates structured notes, dictation, and coding suggestions inside Epic and major EHRs.

Enterprise GradeAPI Available
60
Free TierSOC 2
View details

Wysa

Enterprise Grade

Wysa is an AI-powered mental health support platform that offers safe, clinically backed care for individuals, teams, and health systems. It provides self-help, guided referral, and between-session support through an always-available, anonymous chat interface.

Enterprise GradeAPI Available
60
Free Tier
View details